Flavia Biamonte1, Cirino Botta2, Maria Mazzitelli3, Salvatore Rotundo1, Enrico Maria Trecarichi3, Daniela Foti4, Carlo Torti3, Giuseppe Viglietto1, Daniele Torella5, Francesco Costanzo6. 1. Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. 2. Annunziata Hospital, Cosenza, Italy. 3. Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy. 4. Department of Health Sciences, Magna Græcia University of Catanzaro, Catanzaro, Italy. 5. Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. dtorella@unicz.it. 6. Center of Interdepartmental Services (CIS), "Magna Graecia" University of Catanzaro, Catanzaro, Italy.
Abstract
BACKGROUND: The Sars-CoV-2 can cause severe pneumonia with multiorgan disease; thus, the identification of clinical and laboratory predictors of the progression towards severe and fatal forms of this illness is needed. Here, we retrospectively evaluated and integrated laboratory parameters of 45 elderly subjects from a long-term care facility with Sars-CoV-2 outbreak and spread, to identify potential common patterns of systemic response able to better stratify patients' clinical course and outcome. METHODS: Baseline white blood cells, granulocytes', lymphocytes', and platelets' counts, hemoglobin, total iron, ferritin, D-dimer, and interleukin-6 concentration were used to generate a principal component analysis. Statistical analysis was performed by using R statistical package version 4.0. RESULTS: We identified 3 laboratory patterns of response, renamed as low-risk, intermediate-risk, and high-risk, strongly associated with patients' survival (p < 0.01). D-dimer, iron status, lymphocyte/monocyte count represented the main markers discriminating high- and low-risk groups. Patients belonging to the high-risk group presented a significantly longer time to ferritin decrease (p: 0.047). Iron-to-ferritin-ratio (IFR) significantly segregated recovered and dead patients in the intermediate-risk group (p: 0.012). CONCLUSIONS: Our data suggest that a combination of few laboratory parameters, i.e. iron status, D-dimer and lymphocyte/monocyte count at admission and during the hospital stay, can predict clinical progression in COVID-19.
BACKGROUND: The Sars-CoV-2 can cause severe pneumonia with multiorgan disease; thus, the identification of clinical and laboratory predictors of the progression towards severe and fatal forms of this illness is needed. Here, we retrospectively evaluated and integrated laboratory parameters of 45 elderly subjects from a long-term care facility with Sars-CoV-2 outbreak and spread, to identify potential common patterns of systemic response able to better stratify patients' clinical course and outcome. METHODS: Baseline white blood cells, granulocytes', lymphocytes', and platelets' counts, hemoglobin, total iron, ferritin, D-dimer, and interleukin-6 concentration were used to generate a principal component analysis. Statistical analysis was performed by using R statistical package version 4.0. RESULTS: We identified 3 laboratory patterns of response, renamed as low-risk, intermediate-risk, and high-risk, strongly associated with patients' survival (p < 0.01). D-dimer, iron status, lymphocyte/monocyte count represented the main markers discriminating high- and low-risk groups. Patients belonging to the high-risk group presented a significantly longer time to ferritin decrease (p: 0.047). Iron-to-ferritin-ratio (IFR) significantly segregated recovered and dead patients in the intermediate-risk group (p: 0.012). CONCLUSIONS: Our data suggest that a combination of few laboratory parameters, i.e. iron status, D-dimer and lymphocyte/monocyte count at admission and during the hospital stay, can predict clinical progression in COVID-19.
Authors: Andre C Kalil; Thomas F Patterson; Aneesh K Mehta; Kay M Tomashek; Cameron R Wolfe; Varduhi Ghazaryan; Vincent C Marconi; Guillermo M Ruiz-Palacios; Lanny Hsieh; Susan Kline; Victor Tapson; Nicole M Iovine; Mamta K Jain; Daniel A Sweeney; Hana M El Sahly; Angela R Branche; Justino Regalado Pineda; David C Lye; Uriel Sandkovsky; Anne F Luetkemeyer; Stuart H Cohen; Robert W Finberg; Patrick E H Jackson; Babafemi Taiwo; Catharine I Paules; Henry Arguinchona; Nathaniel Erdmann; Neera Ahuja; Maria Frank; Myoung-Don Oh; Eu-Suk Kim; Seow Y Tan; Richard A Mularski; Henrik Nielsen; Philip O Ponce; Barbara S Taylor; LuAnn Larson; Nadine G Rouphael; Youssef Saklawi; Valeria D Cantos; Emily R Ko; John J Engemann; Alpesh N Amin; Miki Watanabe; Joanne Billings; Marie-Carmelle Elie; Richard T Davey; Timothy H Burgess; Jennifer Ferreira; Michelle Green; Mat Makowski; Anabela Cardoso; Stephanie de Bono; Tyler Bonnett; Michael Proschan; Gregory A Deye; Walla Dempsey; Seema U Nayak; Lori E Dodd; John H Beigel Journal: N Engl J Med Date: 2020-12-11 Impact factor: 176.079
Authors: Ana C Moreira; Maria Jose Teles; Tânia Silva; Clara M Bento; Inês Simões Alves; Luisa Pereira; João Tiago Guimarães; Graça Porto; Pedro Oliveira; Maria Salomé Gomes Journal: Viruses Date: 2021-12-10 Impact factor: 5.048
Authors: Maria T Tsakok; Robert A Watson; David W Eyre; Fergus Gleeson; Shyamal J Saujani; Mark Kong; Cheng Xie; Heiko Peschl; Louise Wing; Fiona K MacLeod; Brian Shine; Nick P Talbot; Rachel E Benamore Journal: Radiology Date: 2022-06-21 Impact factor: 29.146